Asia · Regional markets · Vietnam Investment Review

Kelun Biotech publishes sac TMT breast cancer study in Annals of Oncology

Published by Vietnam Investment Review · Vietnam 8 h ago

Sichuan Kelun-Biotech Biopharmaceutical published overall survival analysis from its Phase III OptiTROP-Breast01 study in Annals of Oncology during the ESMO Congress in Madrid.

Read the full article on Vietnam Investment Review Sign in to save

MarketNews shows the headline and summary published by the outlet. The full article is on the publisher's website. (vir.com.vn)

Also worth reading

CNBC-TV18

Max Financial Services Q2: Value of new business rises to ₹734 crore, total APE at ₹2,716 crore

Mint

United Breweries Q2 results: Profit jumps 190%, revenue rises 24% as premium beer volumes surge; Kingfisher sales up 44%

Business Standard

SpiceJet's domestic market share falls below Star Air for the first time

The Straits Times Business

Anthropic’s IPO filing lifts markets but raises AI safety fears. What should S’pore investors know?

The Business Times

Mapletree Industrial Trust posts 6.6% drop in Q2 DPU to S$0.0297

Tech in Asia